APPB (Applied Biosciences) Issuance of Debt: $0.88 Mil (TTM As of Dec. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APPB Applied Biosciences Corp APPB
12 GF Score
Price $0.00
View Full Analysis

What is Applied Biosciences Issuance of Debt?

Applied Biosciences APPB 12 Issuance of Debt is $0.88 Mil as of Dec. 2019. GuruFocus rates APPB with a GF Score™ of 12/100.

Applied Biosciences's Issuance of Debt for the three months ended in Dec. 2019 was $0.00 Mil.

Applied Biosciences's Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2019 was $0.88 Mil.

Applied Biosciences Issuance of Debt Related Terms

Applied Biosciences Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Applied Biosciences's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied Biosciences Issuance of Debt Chart

Applied Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18
Issuance of Debt
0.00 0.00 0.00 0.00 0.00

Applied Biosciences Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.28 0.09 0.39 0.40 0.00
APPB
12GF Score
Applied Biosciences Corp APPB
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied Biosciences Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $0.88 Mil mean?
Applied Biosciences (APPB) has a Issuance of Debt of $0.88 Mil as of Dec. 2019. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Applied Biosciences and its competitors.
Is Applied Biosciences' Issuance of Debt too high?
Applied Biosciences' current Issuance of Debt is $0.88 Mil. Overall, Applied Biosciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Applied Biosciences' Issuance of Debt compare to CNABQ and OWCP?
Applied Biosciences' Issuance of Debt of $0.88 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Applied Biosciences and its competitors. Applied Biosciences's current Issuance of Debt is $0.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied Biosciences stock overvalued right now?
Applied Biosciences (APPB) has a current Issuance of Debt of $0.88 Mil. The current Issuance of Debt is $0.88 Mil. Applied Biosciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Applied Biosciences (APPB), the current Issuance of Debt is $0.88 Mil as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Applied Biosciences Business Description

Address 112 North Curry Street, 18th Floor, Carson, NY, USA, 89703
Applied Biosciences Corp is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics / biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. The company also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to its customers.
12GF Score

Get the complete analysis for APPB

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price